Moderna, Inc. ADR (MRNA)
BCBA
Closed
Sep 21, 2026
Day's Range
13,960.0052 wk Range
1,758.00Overview - MRNA - Moderna, Inc. ADR
Key Statistics
Valuation
Enterprise Value
72,352.17T
Price / Book
‪4.76‬
EV / EBITDA
‪-21,860.73‬
Profitability
Profit Margin
‪-141.42%‬
Operating Margin
‪-557.93%‬
Return on Assets
‪-13.25%‬
Return on Equity
‪-38.99%‬
Ownership
Float
3.72B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.10‬
50-Day Avg
‪7,950.15‬
200-Day Avg
‪4,703.76‬
Peers - MRNA - Moderna, Inc. ADR
Peer Comparison
Compared with other Stocks.
- MRNABCBAModerna, Inc. ADR+83.91%52-week change—P/E (Trailing)‪-141.42%‬Profit Margin
- SIEGYBCBASiemens Aktiengesellschaft+90.18%52-week change27.66P/E (Trailing)‪9.79%‬Profit Margin
- MUBCBAMicron Technology, Inc. - CEDEAR+85.39%52-week change42307.19P/E (Trailing)‪55.90%‬Profit Margin
- AMDBCBAAdvanced Micro Devices Inc Canadian Depositary Receipt+73.92%52-week change14.85P/E (Trailing)‪15.57%‬Profit Margin
- FMCCBCBAFreddie Mac Cedear+97.57%52-week change-220000.00P/E (Trailing)‪52.62%‬Profit Margin
- EDSHBCBAEdesa Holding S.A.+98.45%52-week change1.26P/E (Trailing)‪14.25%‬Profit Margin
- ININTCDBCBAIntel Corporation - CEDEAR+76.80%52-week change0.17P/E (Trailing)‪-19.79%‬Profit Margin
Profile Summary - MRNA - Moderna, Inc. ADR
About
Moderna, Inc. is a biotechnology company specializing in the discovery, development, and commercialization of medicines based on messenger RNA technology. Its primary purpose is to translate genetic instructions into therapeutic proteins inside the body, enabling vaccines and treatments that can be designed and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
